65 related articles for article (PubMed ID: 21160189)
21. [Relationship between RAR-beta gene expression defect and its methylation].
Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the hBiot2 gene is associated with development of human cervical cancer.
Shen YM; He X; Deng HX; Xie YP; Wang CT; Wei YQ; Zhao X
Oncol Rep; 2011 Jan; 25(1):75-80. PubMed ID: 21109960
[TBL] [Abstract][Full Text] [Related]
23. cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy.
Borkamo ED; Schem BC; Fluge Ø; Bruland O; Dahl O; Mella O
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1562-9. PubMed ID: 19931738
[TBL] [Abstract][Full Text] [Related]
24. Clinical validation of a customized multiple signature microarray for breast cancer.
Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
[TBL] [Abstract][Full Text] [Related]
25. Differential gene expression in cervical cancer cell lines before and after ionizing radiation.
Liu SS; Cheung AN; Ngan HY
Int J Oncol; 2003 May; 22(5):1091-9. PubMed ID: 12684676
[TBL] [Abstract][Full Text] [Related]
26. Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma.
Harima Y; Nagata K; Harima K; Oka A; Ostapenko VV; Shikata N; Ohnishi T; Tanaka Y
Cancer; 2000 Jan; 88(1):132-8. PubMed ID: 10618615
[TBL] [Abstract][Full Text] [Related]
27. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
[TBL] [Abstract][Full Text] [Related]
29. Expression of RAR beta2 gene by real-time RT-PCR: differential expression in normal subjects compared to cervical cancer patients normalised against GAPDH as a housekeeping gene.
Abu J; Batuwangala M; Symonds P
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):295-6. PubMed ID: 18547710
[No Abstract] [Full Text] [Related]
30. Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128.
Zempolich K; Fuhrman C; Milash B; Flinner R; Greven K; Ryu J; Forbes A; Kerlin K; Nichols RC; Gaffney DK
Gynecol Oncol; 2008 May; 109(2):275-9. PubMed ID: 18299147
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy.
Martin CM; Astbury K; McEvoy L; O'Toole S; Sheils O; O'Leary JJ
Methods Mol Biol; 2009; 511():333-59. PubMed ID: 19347305
[TBL] [Abstract][Full Text] [Related]
32. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
33. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
34. Predictive and prognostic significance of glutathione levels and DNA damage in cervix cancer patients undergoing radiotherapy.
Vidyasagar MS; Kodali M; Prakash Saxena P; Upadhya D; Murali Krishna C; Vadhiraja BM; Fernandes DJ; Bola Sadashiva SR
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):343-9. PubMed ID: 20133070
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
[TBL] [Abstract][Full Text] [Related]
36. A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression.
Nalbandian A; Pang AL; Rennert OM; Chan WY; Ravindranath N; Djakiew D
Differentiation; 2005 Oct; 73(8):385-96. PubMed ID: 16316409
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines.
Kubota H; Suzuki T; Lu J; Takahashi S; Sugita K; Sekiya S; Suzuki N
Int J Radiat Biol; 2005 Sep; 81(9):701-9. PubMed ID: 16368648
[TBL] [Abstract][Full Text] [Related]
38. The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.
Santin AD; Cane' S; Bellone S; Bignotti E; Palmieri M; De Las Casas LE; Anfossi S; Roman JJ; O'Brien T; Pecorelli S
Cancer; 2003 Nov; 98(9):1898-904. PubMed ID: 14584072
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix].
Gasparian NA; Pozharisskiĭ KM; Zharinov GM; Vinokurov VL; Kuznetsova ME; Neklasova NIu
Vopr Onkol; 2007; 53(4):439-44. PubMed ID: 17969407
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
